a

Donec quam felis, ultricies nec, pellentesque eu, pretium quis, sem nulla consequat. Aenean massa.

AWARDS AND RECOGNITION

2018

Awarded by Janssen as TOP RECRUITER IN ASIA

Awarded by Parexel as TOP RECRUITER FOR ONE STUDY BY 140% OR HIGHER THAN THE AVERAGE SITE to Assoc. Prof. Dr. Pang Yong Kek.

Awarded by Gilead Science as FIRST SITE TO RANDOMIZE PATIENT IN MALAYSIA

2017

Awarded by Parexel as TOP RECRUITER IN MALAYSIA FOR TWO STUDIES

Awarded by IQVIA as FIRST PATIENT ENROLLMENT IN THE WORLD

Awarded byIQVIA as PRIME SITES(1ST POSITION IN MALAYSIA), TOP-5 APAC (3RD POSITION) & TOP-10 GLOBAL PROME SITE (7TH POSITION)

Awarded by IQVIA as SUPERIOR PERFORMANCE AND QUALITY IN CLINICAL RESEARCH

Awarded by IQVIA as SUPERIOR PERFORMANCE AND QUALITY IN CLINICAL RESEARCH

2016

Recognised by PAREXEL as THE FIRST PAREXEL ALLIANCE SITE IN MALAYSIA

Awarded by Pfizer as SITE INSPIRE (INVESTIGATOR NETWORKS, SITE PARTNERSHIPS AND INFRASTRUCTURE FOR RESEARCH EXCELLENCE) SITE OF PFIZER FOR YEAR 2016

2015

Awarded by Pfizer as SITE INSPIRE (INVESTIGATOR NETWORKS, SITE PARTNERSHIPS AND INFRASTRUCTURE FOR RESEARCH EXCELLENCE) SITE OF PFIZER FOR YEAR 2015

2014

Awarded by Pfizer as SITE INSPIRE (INVESTIGATOR NETWORKS, SITE PARTNERSHIPS AND INFRASTRUCTURE FOR RESEARCH EXCELLENCE) SITE OF PFIZER FOR YEAR 2014

Recognised by Quintiles as BEING THE ONLY PRIMESITE IN ASIA PASIFIC REGION THAT HAS ALL NEW STUDIES RECRUIT THE FIRST PATIENT WITHIN 100 DAYS

2014, Recognised by Quintiles as BEING THE ONLY PRIMESITE IN ASIA PASIFIC REGION THAT HAS ALL NEW STUDIES RECRUIT THE FIRST PATIENT WITHIN 100 DAYSAugust 2014, Awarded by Quintiles as BEST STUDY COORDINATOR AWARD- DR ZAINAB ABU KASSIM

2013

Awarded by Pfizer. Inc as the FIRST SITE OF INSPIRE PROGRAM IN MALAYSIA

May 2013, Recognised by Quintiles AWARDED BEST PRIME SITE IN THE WORLD FOR RECRUITMENT NUMBER AT THE HALF-YEAR MARK OF 2013

September 2013, category: Best Pharma Clinical Trial Service Provider WINNER FOR ASIAN MANUFACTURING AWARDS

2010

Recognised by Quintiles as the FIRST PRIME SITE IN ASIA FOR CONDUCT OF CLINICAL TRIAL